Photosensitive organic compounds that release carbon monoxide upon
申请人:University Of Maryland Biotechnology Institute
公开号:US05670664A1
公开(公告)日:1997-09-23
The present invention relates to acetal derivatives of bicyclo\x9b2.2.1!hepta-2,5-diene-7-one (norbornadienone) which are capable of releasing carbon monoxide upon irradiation with ultraviolet light, and a method for producing carbon monoxide employing the same.
PHENYLALKYL SULFAMATE COMPOUND AND MUSCLE RELAXANT COMPOSITION COMPRISING THE SAME
申请人:Bio-Pharm Solutions Co., Ltd.
公开号:EP2861571B1
公开(公告)日:2017-05-03
SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN
申请人:Bio-Pharm Solutions Co., Ltd.
公开号:EP3079685A1
公开(公告)日:2016-10-19
US5670664A
申请人:——
公开号:US5670664A
公开(公告)日:1997-09-23
[EN] SULFAMATE DERIVATIVE COMPOUNDS FOR USE IN TREATING OR ALLEVIATING PAIN<br/>[FR] COMPOSÉS DE DÉRIVÉ DE SULFAMATE À UTILISER DANS LE TRAITEMENT OU L'ATTÉNUATION DE LA DOULEUR
申请人:BIO PHARM SOLUTIONS CO LTD
公开号:WO2015088273A1
公开(公告)日:2015-06-18
The present invention relates to sulfamate derivative compounds and a composition for treating and/or alleviating pain containing the sulfamate derivative compounds or a pharmaceutically acceptable salt thereof as an active ingredient. More specifically, the present invention relates to a pharmaceutical composition for treating or alleviating pain containing a sulfamate derivative compound and/or a pharmaceutically acceptable salt thereof as an active ingredient. Furthermore, the present invention relates to a method for treatment or alleviation of pain comprising administering a sulfamate derivative compound in a pharmaceutically effective amount to a subject in need of treatment or alleviation of pain; and a use of the sulfamate derivative compound or the pharmaceutically acceptable salt thereof in treating and/or alleviating pain, are provided.